Total amount: € 0,00
Indexed/Abstracted in: EMBASE, Scopus, Emerging Sources Citation Index
Online ISSN 1827-1782
Tanaka K., Naruse Y., Tabata A.
Department of Cardiovascular Surgery, Cardiovascular Center, Toranomon Hospital, Toranomon, Tokyo, Japan
Aim. Little has been reported on the effect of continuous ambulatory peritoneal dialysis (CAPD) as the primary dialysis treatment after open heart surgery in dialysis-dependent adults. The purpose of this study was to evaluate the clinical results of aortic valve replacement for dialysis patients and to comfirm the validity of temporary CAPD.
Methods. In a retrospective study, we reviewed the surgical results of 41 dialysis patients (mean age 65.6±7.6 years, 31 men) undergoing aortic valve replacement: CAPD was the temporary dialysis treatment during the acute postoperative period in 34 of these patients (group C). Mean follow-up time was 4.0±3.7 years.
Results. The overall hospital mortality was 7.3% (3 patients, 1 in group C). CAPD was performed for 9.2±6.1 days. There were no cases of stroke or mesenteric ischemia in group C. Only 2 patients in group C (5.9%) required glucose-insulin therapy. Eight episodes of suspicion of CAPD peritonitis were encountered; however, all were aseptic and were successfully treated with irrigation and antibiotic therapy. The overall 3-, 5-, and 10-year Kaplan-Meier survival rates were 72.3±7.6%, 57.1±9.0%, and 38.9±1 1.5%, respectively.
Conclusion. Our study demonstrates good early and long-term clinical results of aortic valve replacement in dialysis patients. CAPD is a safe and valid temporary dialysis method during the acute postoperative period after aortic valve replacement in dialysis patients.